Global Biologic-Device Combination Products Market Research Report 2023

Publication ID:

PB501231384

Publication Date:

January 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A biologic-device combination product is a marriage between two partners with "cultural differences". There are clear differences in the development, review, and commercialization processes of the biologic and the device. Some biological products are associated with a device or drug to form a therapeutic product.
Highlights
The global Biologic-Device Combination Products market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biologic-Device Combination Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Biologic-Device Combination Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Biologic-Device Combination Products in Vaccines is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Biologic-Device Combination Products include BD, Gerresheimer, Nipro Corporation, Schott, Stevanato, Baxter BioPharma Solution, Rovi CM, Terumo and Vetter, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biologic-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic-Device Combination Products.
The Biologic-Device Combination Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biologic-Device Combination Products market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Baxter BioPharma Solution
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
Roselabs Group
West Pharma
Segment by Type
Prefilled Syringes
Autoinjectors
Others
Segment by Application
Vaccines
Antithrombotic Drugs
Bioengineering Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic-Device Combination Products companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic-Device Combination Products Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Prefilled Syringes
1.2.3 Autoinjectors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biologic-Device Combination Products Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Vaccines
1.3.3 Antithrombotic Drugs
1.3.4 Bioengineering Drugs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic-Device Combination Products Market Perspective (2018-2029)
2.2 Biologic-Device Combination Products Growth Trends by Region
2.2.1 Global Biologic-Device Combination Products Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biologic-Device Combination Products Historic Market Size by Region (2018-2023)
2.2.3 Biologic-Device Combination Products Forecasted Market Size by Region (2024-2029)
2.3 Biologic-Device Combination Products Market Dynamics
2.3.1 Biologic-Device Combination Products Industry Trends
2.3.2 Biologic-Device Combination Products Market Drivers
2.3.3 Biologic-Device Combination Products Market Challenges
2.3.4 Biologic-Device Combination Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic-Device Combination Products Players by Revenue
3.1.1 Global Top Biologic-Device Combination Products Players by Revenue (2018-2023)
3.1.2 Global Biologic-Device Combination Products Revenue Market Share by Players (2018-2023)
3.2 Global Biologic-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologic-Device Combination Products Revenue
3.4 Global Biologic-Device Combination Products Market Concentration Ratio
3.4.1 Global Biologic-Device Combination Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic-Device Combination Products Revenue in 2022
3.5 Biologic-Device Combination Products Key Players Head office and Area Served
3.6 Key Players Biologic-Device Combination Products Product Solution and Service
3.7 Date of Enter into Biologic-Device Combination Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic-Device Combination Products Breakdown Data by Type
4.1 Global Biologic-Device Combination Products Historic Market Size by Type (2018-2023)
4.2 Global Biologic-Device Combination Products Forecasted Market Size by Type (2024-2029)
5 Biologic-Device Combination Products Breakdown Data by Application
5.1 Global Biologic-Device Combination Products Historic Market Size by Application (2018-2023)
5.2 Global Biologic-Device Combination Products Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biologic-Device Combination Products Market Size (2018-2029)
6.2 North America Biologic-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biologic-Device Combination Products Market Size by Country (2018-2023)
6.4 North America Biologic-Device Combination Products Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologic-Device Combination Products Market Size (2018-2029)
7.2 Europe Biologic-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biologic-Device Combination Products Market Size by Country (2018-2023)
7.4 Europe Biologic-Device Combination Products Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic-Device Combination Products Market Size (2018-2029)
8.2 Asia-Pacific Biologic-Device Combination Products Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biologic-Device Combination Products Market Size by Region (2018-2023)
8.4 Asia-Pacific Biologic-Device Combination Products Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologic-Device Combination Products Market Size (2018-2029)
9.2 Latin America Biologic-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biologic-Device Combination Products Market Size by Country (2018-2023)
9.4 Latin America Biologic-Device Combination Products Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic-Device Combination Products Market Size (2018-2029)
10.2 Middle East & Africa Biologic-Device Combination Products Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biologic-Device Combination Products Market Size by Country (2018-2023)
10.4 Middle East & Africa Biologic-Device Combination Products Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD Biologic-Device Combination Products Introduction
11.1.4 BD Revenue in Biologic-Device Combination Products Business (2018-2023)
11.1.5 BD Recent Development
11.2 Gerresheimer
11.2.1 Gerresheimer Company Detail
11.2.2 Gerresheimer Business Overview
11.2.3 Gerresheimer Biologic-Device Combination Products Introduction
11.2.4 Gerresheimer Revenue in Biologic-Device Combination Products Business (2018-2023)
11.2.5 Gerresheimer Recent Development
11.3 Nipro Corporation
11.3.1 Nipro Corporation Company Detail
11.3.2 Nipro Corporation Business Overview
11.3.3 Nipro Corporation Biologic-Device Combination Products Introduction
11.3.4 Nipro Corporation Revenue in Biologic-Device Combination Products Business (2018-2023)
11.3.5 Nipro Corporation Recent Development
11.4 Schott
11.4.1 Schott Company Detail
11.4.2 Schott Business Overview
11.4.3 Schott Biologic-Device Combination Products Introduction
11.4.4 Schott Revenue in Biologic-Device Combination Products Business (2018-2023)
11.4.5 Schott Recent Development
11.5 Stevanato
11.5.1 Stevanato Company Detail
11.5.2 Stevanato Business Overview
11.5.3 Stevanato Biologic-Device Combination Products Introduction
11.5.4 Stevanato Revenue in Biologic-Device Combination Products Business (2018-2023)
11.5.5 Stevanato Recent Development
11.6 Baxter BioPharma Solution
11.6.1 Baxter BioPharma Solution Company Detail
11.6.2 Baxter BioPharma Solution Business Overview
11.6.3 Baxter BioPharma Solution Biologic-Device Combination Products Introduction
11.6.4 Baxter BioPharma Solution Revenue in Biologic-Device Combination Products Business (2018-2023)
11.6.5 Baxter BioPharma Solution Recent Development
11.7 Rovi CM
11.7.1 Rovi CM Company Detail
11.7.2 Rovi CM Business Overview
11.7.3 Rovi CM Biologic-Device Combination Products Introduction
11.7.4 Rovi CM Revenue in Biologic-Device Combination Products Business (2018-2023)
11.7.5 Rovi CM Recent Development
11.8 Terumo
11.8.1 Terumo Company Detail
11.8.2 Terumo Business Overview
11.8.3 Terumo Biologic-Device Combination Products Introduction
11.8.4 Terumo Revenue in Biologic-Device Combination Products Business (2018-2023)
11.8.5 Terumo Recent Development
11.9 Vetter
11.9.1 Vetter Company Detail
11.9.2 Vetter Business Overview
11.9.3 Vetter Biologic-Device Combination Products Introduction
11.9.4 Vetter Revenue in Biologic-Device Combination Products Business (2018-2023)
11.9.5 Vetter Recent Development
11.10 Catalent
11.10.1 Catalent Company Detail
11.10.2 Catalent Business Overview
11.10.3 Catalent Biologic-Device Combination Products Introduction
11.10.4 Catalent Revenue in Biologic-Device Combination Products Business (2018-2023)
11.10.5 Catalent Recent Development
11.11 Taisei Kako
11.11.1 Taisei Kako Company Detail
11.11.2 Taisei Kako Business Overview
11.11.3 Taisei Kako Biologic-Device Combination Products Introduction
11.11.4 Taisei Kako Revenue in Biologic-Device Combination Products Business (2018-2023)
11.11.5 Taisei Kako Recent Development
11.12 Roselabs Group
11.12.1 Roselabs Group Company Detail
11.12.2 Roselabs Group Business Overview
11.12.3 Roselabs Group Biologic-Device Combination Products Introduction
11.12.4 Roselabs Group Revenue in Biologic-Device Combination Products Business (2018-2023)
11.12.5 Roselabs Group Recent Development
11.13 West Pharma
11.13.1 West Pharma Company Detail
11.13.2 West Pharma Business Overview
11.13.3 West Pharma Biologic-Device Combination Products Introduction
11.13.4 West Pharma Revenue in Biologic-Device Combination Products Business (2018-2023)
11.13.5 West Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Baxter BioPharma Solution
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
Roselabs Group
West Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂